4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / HIS Bundle Pacing Synchrony Comparing HIS Pacing to Intrinsic Conduction While Using the Medtronic ECG Belt System

HIS Bundle Pacing Synchrony Comparing HIS Pacing to Intrinsic Conduction While Using the Medtronic ECG Belt System

Study Description
Brief Summary:
The HBP Synchrony Using ECG Belt study is a prospective, non-randomized single site physician-initiated research study. The study will collect ECG Belt data from up to 30 subjects at one single center. The target population will include subjects with a currently implanted Medtronic cardiac implantable device who have a HIS placed lead. The purpose of the study is to characterize the electrical dispersion using the ECG Belt provided by Medtronic in patients who have a HIS placed lead and understanding the amount of synchrony with intrinsic conduction compared to HIS pacing.

Condition or disease
HBP

Study Design
Layout table for study information
Study Type : Observational
Estimated Enrollment : 30 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: HBP Synchrony Using ECG Belt
Actual Study Start Date : June 1, 2021
Estimated Primary Completion Date : March 1, 2022
Estimated Study Completion Date : May 1, 2022
Arms and Interventions
Outcome Measures
Primary Outcome Measures :
  1. Characterize the electrical dispersion using SDAT [ Time Frame: 1 year ]
    Characterize the electrical dispersion between intrinsic to both Selective HIS pacing and Non-Selective HIS pacing using Standard Deviation Activation Timing of the ECG Belt system.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
The target population will include subjects with normal EF who have a Medtronic device and a HIS placed RV lead. In addition, we will include subjects who have intact AV conduction.
Criteria

Inclusion Criteria:

  • Patient has previously been implanted with a Medtronic IPG/ICD and a HIS placed RV lead
  • Patient has intrinsic AV conduction
  • Normal EF, defined as EF >50%, as shown on recent echo within last 12 months
  • Patient is willing and able to comply with the protocol
  • Patient is 18 years of age or older

Exclusion Criteria:

●Patient is ventricular pacer dependent

Contacts and Locations

Locations
Layout table for location information
United States, Florida
Orlando Cardiac & Vascular Specialists Recruiting
Altamonte Springs, Florida, United States, 32701
Contact: Sambit Mondal, MD    407-915-5643    sambitmondal@gmail.com   
Sponsors and Collaborators
SAMBIT MONDAL
Tracking Information
First Submitted Date June 11, 2021
First Posted Date June 18, 2021
Last Update Posted Date June 18, 2021
Actual Study Start Date June 1, 2021
Estimated Primary Completion Date March 1, 2022   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: June 11, 2021)
Characterize the electrical dispersion using SDAT [ Time Frame: 1 year ]
Characterize the electrical dispersion between intrinsic to both Selective HIS pacing and Non-Selective HIS pacing using Standard Deviation Activation Timing of the ECG Belt system.
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title HIS Bundle Pacing Synchrony Comparing HIS Pacing to Intrinsic Conduction While Using the Medtronic ECG Belt System
Official Title HBP Synchrony Using ECG Belt
Brief Summary The HBP Synchrony Using ECG Belt study is a prospective, non-randomized single site physician-initiated research study. The study will collect ECG Belt data from up to 30 subjects at one single center. The target population will include subjects with a currently implanted Medtronic cardiac implantable device who have a HIS placed lead. The purpose of the study is to characterize the electrical dispersion using the ECG Belt provided by Medtronic in patients who have a HIS placed lead and understanding the amount of synchrony with intrinsic conduction compared to HIS pacing.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population The target population will include subjects with normal EF who have a Medtronic device and a HIS placed RV lead. In addition, we will include subjects who have intact AV conduction.
Condition HBP
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: June 11, 2021)
30
Original Estimated Enrollment Same as current
Estimated Study Completion Date May 1, 2022
Estimated Primary Completion Date March 1, 2022   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Patient has previously been implanted with a Medtronic IPG/ICD and a HIS placed RV lead
  • Patient has intrinsic AV conduction
  • Normal EF, defined as EF >50%, as shown on recent echo within last 12 months
  • Patient is willing and able to comply with the protocol
  • Patient is 18 years of age or older

Exclusion Criteria:

●Patient is ventricular pacer dependent

Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers Not Provided
Contacts
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT04930601
Other Study ID Numbers OSCMondal062021
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
IPD Sharing Statement
Plan to Share IPD: Undecided
Responsible Party SAMBIT MONDAL, Orlando Cardiac and Vascular Specialists
Study Sponsor SAMBIT MONDAL
Collaborators Not Provided
Investigators Not Provided
PRS Account Orlando Cardiac and Vascular Specialists
Verification Date June 2021